Viewing Study NCT06510660


Ignite Creation Date: 2025-12-25 @ 2:09 AM
Ignite Modification Date: 2026-02-25 @ 7:07 PM
Study NCT ID: NCT06510660
Status: RECRUITING
Last Update Posted: 2024-09-19
First Post: 2024-04-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Adebrelimab ±Induction Chemotherapy Followed by Concurrent Chemoradiotherapy for Unresectable Locally Advanced ESCC
Sponsor: Fujian Medical University Union Hospital
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Esophageal Squamous Cell Carcinoma View
None Immunotherapy View
None Biomarkers View
Keywords: